Literature DB >> 3275555

Low-dose streptozocin-induced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset.

V Kolb-Bachofen1, S Epstein, U Kiesel, H Kolb.   

Abstract

We investigated the morphology of mouse islets 5 days after completion of low-dose streptozocin treatment of C57BL/6 mice by electron microscopy. At this stage, mice were still normoglycemic and light microscopy did not reveal massive islet infiltration. The electron-microscopic investigation revealed two characteristics indicative of ongoing islet cell destruction. In all islets investigated, lysed islet beta-cells were recognized by disrupted plasma membranes and concomitantly decreased plasma contrast. Many of the lysed islet beta-cells still contained numerous insulin granules. We also found immunocytes scattered throughout the islets, most of which could be identified as macrophages. Some were found engaged in phagocytosis of islet beta-cell debris. This early stage of islet lesion termed single-cell insulitis is followed by the well-known later stage of massive infiltration easily recognized in light microscopy. Administration of silica particles to mice treated with low-dose streptozocin inhibited macrophage infiltration of islets as shown by immunocytochemistry with macrophage-specific monoclonal antibody F4/80. In parallel, the development of hyperglycemia was suppressed. The observations favor a pathogenic role of macrophages in islet destruction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275555     DOI: 10.2337/diab.37.1.21

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

Review 1.  Environmental factors in the development of Type 1 diabetes.

Authors:  Hui Peng; William Hagopian
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

2.  Interference of H2O2 with stimulus-secretion coupling in mouse pancreatic beta-cells.

Authors:  P Krippeit-Drews; C Kramer; S Welker; F Lang; H P Ammon; G Drews
Journal:  J Physiol       Date:  1999-01-15       Impact factor: 5.182

Review 3.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

4.  Insulitis and islet-cell antibody formation in rats with experimentally reduced beta-cell mass.

Authors:  E F Lampeter; M Tubes; C Klemens; U Brocker; J Friemann; V Kolb-Bachofen; F A Gries; H Kolb
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

5.  Modulation of low-dose streptozotocin-induced diabetes in mice by administration of antibodies to I-A, I-E and I-J determinants.

Authors:  U Kiesel; M Oschilewski; M Taniguchi; H Kolb
Journal:  Diabetologia       Date:  1989-03       Impact factor: 10.122

6.  Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil.

Authors:  D Maksimovic-Ivanic; V Trajkovic; D J Miljkovic; M Mostarica Stojkovic; S Stosic-Grujicic
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

7.  Pancreatic duct inflammatory infiltration in the nonobese diabetic (NOD) mouse.

Authors:  G Papaccio; G C Baccari; C Strate; T Linn
Journal:  J Anat       Date:  1994-12       Impact factor: 2.610

8.  Pygeum africanum: effect on oxidative stress in early diabetes-induced bladder.

Authors:  Dan Wang; Yongzhi Li; Guihua Hou; Ping Wang; Jianping Zhang; Vincent Laudon; Benkang Shi
Journal:  Int Urol Nephrol       Date:  2009-07-16       Impact factor: 2.370

9.  The role of cytotoxic macrophages in non-obese diabetic mice: cytotoxicity against murine mastocytoma and beta-cell lines.

Authors:  A Kasuga; T Maruyama; I Takei; A Shimada; T Kasatani; K Watanabe; T Saruta; T Nakaki; S Habu; J Miyazaki
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

10.  Morphological observations on pancreatic islet blood vessels in low-dose streptozocin-treated mice.

Authors:  G Papaccio; T Linn; G Chieffi Baccari
Journal:  J Anat       Date:  1993-02       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.